Price $18.43 |
Market Cap
170M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
6.85
|
P/S
4.56
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-600
|
FCF
-0.1
|
|
Op. Margin
-8.20%
|
Net Margin
-20.80%
|
ROE
-30.10%
|
ROI
-27.10%
|
|
ROA
-25.50%
|
EPS Growth
-317.10%
|
Current Ratio
4.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Imprimis Pharmaceuticals Inc (IMMY) | $2.95 | - | - | 58.7M | Strong Buy |
| Digirad Corporation (DRAD) | $1.45 | - | 14.70% | 31.2M | Strong Buy |
| Altimmune Inc (ALT) | $4.16 | - | - | 17.4M | Strong Buy |
| Endo International PLC (ENDP) | $17.51 | - | - | 3.62B | Strong Buy |
| Quorum Health Corp (QHC) | $4.05 | - | - | 167.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
